Keywords: Tipranavir; Stability; Degradation products; Oxidation; Capillary zone electrophoresis; High resolution mass spectrometry;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: in vitro/in vivo correlations (IVIVC); hepatic transport; hepatic metabolism; hepatic clearance; hepatocytes; HIV/AIDS; membrane transport; metabolism; organic anion-transporting polypeptide transporters; APV; amprenavir; ATV; atazanavir; CHO; Chinese h
Core-shell nanoparticles for targeted and combination antiretroviral activity in gut-homing T cells
Keywords: Targeted drug delivery; Lipid-polymer hybrid nanoparticles; α4β7 Monoclonal antibody; GALT; Gut-homing T cell; HIV-1; α4β7 mAb; monoclonal antibody against α4β7 integrin; A4B7-LCNP; LCNP surface conjugated with α4β7 mAb; APC anti-α4β7; α4β7 mA
Efectividad y seguridad de la terapia de rescate en pacientes VIH
Keywords: Efectividad; Seguridad; Enfuvirtida; Darunavir; Tipranavir; Etravirina; VIH; Paciente multirresistente; Pauta de rescate; Effectiveness; Safety; Enfuvirtide; Darunavir; Tipranavir; Etravirine; HIV; Multidrug-resistant patients; Salvage therapy;
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba
Keywords: ART; antiretroviral therapy; CI; confidence interval; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside RTI; PI; protease inhibitor; FCR; full-class resistance; CRF; circulating recombinant form; HIV; human immunodeficiency virus; MD
The higher barrier of darunavir and tipranavir resistance for HIV-1 protease
Keywords: Darunavir; Tipranavir; Multi-drug resistant HIV-1 protease; X-ray crystallography;
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Keywords: Buprenorphine-naloxone; Tipranavir; Ritonavir; Pharmacokinetics; HIV/AIDS; Substance abuse; Pharmacotherapy; Antiviral treatment; Maintenance; Opiates;
Tipranavir exhibits different effects on opportunistic pathogenic fungi
Keywords: Tipranavir; Protease inhibitors; HIV; Candida albicans; Cryptococcus neoformans; Fungi; Opportunistic pathogens; AIDS;
New treatment options for HIV salvage patients: An overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists
Keywords: Salvage therapy; Etravirine; Tipranavir; Darunavir; Raltegravir; Maraviroc
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method
Keywords: Tipranavir; UV detector; Liquid/liquid extraction; TDM
High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications
Keywords: Tipranavir; High-performance liquid chromatography (HPLC); Antiretroviral drug; Protease inhibitor; Therapeutic drug monitoring
Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection
Keywords: Tipranavir; Liquid chromatography; UV detection
Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC–UV after solid-phase extraction
Keywords: Tipranavir; Protease inhibitors; Therapeutic drug monitoring; Ion pair HPLC; Solid-phase extraction
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir
Keywords: Tipranavir; HIV; Resistance;